glow bpc-157 (BPC-157/TB-500/GHK-Cu) — IVs in the Keys GHK‑Cu / BPC‑157 / TB‑500
Description
ALIMTA is indicated as monotherapy for the second line treatment of patients with locally advanced or metastatic nonsmall cell lung cancer other than predominantly squamous cell histology
The vial still contains 10 mg regardless of dilution
It's sterile water for injection that contains 0.9% benzyl alcohol, which acts as a preservative
For Patients : If you are struggling with a chronic injury that wont resolve, debilitating gut issues, or persistent inflammation, this peptide could be a game-changer
